Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079297 | SCV000111167 | benign | not specified | 2013-07-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000079297 | SCV000167474 | benign | not specified | 2011-07-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000079297 | SCV000305452 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000248885 | SCV000317419 | benign | Cardiovascular phenotype | 2015-03-09 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000860167 | SCV001000118 | benign | Long QT syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554436 | SCV001775681 | benign | Timothy syndrome | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004706481 | SCV005234218 | benign | not provided | criteria provided, single submitter | not provided |